Our Mission is to equip every Critical Access and Rural Hospital in America with PIR
CONNECTING HOSPITALs/ PATIENTS & PIR
Through Well Cell Global’s PIR, We are building Metabolic Centers of Excellence
PIR® FOR THE PATIENT
What is Physiologic Insulin Resensitization
What is Physiologic Insulin Resensitization
What is Physiologic Insulin Resensitization
Well Cell’s patented approach called Physiologic Insulin Resensitization® is directed by physicians to help patients with insulin resistance.
Through the use of Physician-Directed Physiologic Insulin Resensitization (PIR), the physician can administer insulin more precisely, as a hormone rather than a drug. Using insulin in a manner that bio-mimics normal physiology, PIR is designed to help physicians to reduce their patients’ insulin resistance, which may help blood sugar more readily enter each cell and be converted into energy.
System Suppression vs. Symptom Elimination
What is Physiologic Insulin Resensitization
What is Physiologic Insulin Resensitization
Published literature tells us that insulin has been used since 1922 as a “drug” to suppress symptoms of high blood sugar after they start. Well Cell assists physicians to use insulin intravenously as a “hormone communicator” in a physiologic way similar to the body’s manner of maintaining metabolism.
Typical PIR Care Plan for each Patient
What is Physiologic Insulin Resensitization
Typical PIR Care Plan for each Patient
Every patient’s degree of insulin resistance and glucose metabolism is unique; so the physician begins with a consultation to determine medical necessity and prescribe an individualized care plan.
Each patient’s unique care plan typically may include an “Induction Phase” for about 90 days, and an ongoing “Maintenance Phase” for the physician to help the patient achieve better glucose metabolism and insulin sensitivity.